 effect alpha-interferon bone marrow megakaryocytes production rate essential thrombocythemia patients essential thrombocythemia ET platelets megakaryocyte morphometry relation platelet production rate bone marrow megakaryocytes IFN therapy significant decrease platelet count IFN therapy platelet baseline months IFN therapy /L /L /L decrement platelet count result diminished platelet production rate baseline months IFN therapy platelets/d platelets/d platelets/d slight shortening platelet mean life-span MLS response IFN treatment MLS days baseline days months IFN therapy IFN significant decrease bone marrow megakaryocyte volume nuclear cytoplasmatic volumes mean megakaryocyte volume pL/microL baseline pL/microL months IFN therapy number megakaryocytes significant change response IFN alpha-IFN reduces platelet production rate peripheral platelet count ET anti-proliferative action megakaryocytes degree shortening platelet MLS